Rankings
▼
Calendar
ATYR FY 2023 Earnings — aTyr Pharma, Inc. Revenue & Financial Results | Market Cap Arena
ATYR
aTyr Pharma, Inc.
$93M
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$353,000
-96.6% YoY
Gross Profit
$353,000
100.0% margin
Operating Income
-$55M
-15557.8% margin
Net Income
-$50M
-14274.5% margin
EPS (Diluted)
$-0.94
Cash Flow
Operating Cash Flow
-$33M
Free Cash Flow
-$37M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$121M
Total Liabilities
$30M
Stockholders' Equity
$91M
Cash & Equivalents
$23M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$353,000
$10M
-96.6%
Gross Profit
$353,000
$9M
-95.9%
Operating Income
-$55M
-$46M
-18.3%
Net Income
-$50M
-$45M
-11.1%
← Q4 2022
All Quarters
Q1 2023 →